Identification of epigallocatechin-3-O-gallate as an active constituent in tea extract that suppresses transcriptional up-regulations of the histamine H1 receptor and interleukin-4 genes

Journal of Traditional Medicines

Volumn 25, Issue 42496, 2008, Pages 133-142

  Matsushita, Chiyo ^a   Mizuguchi, Hiroyuki ^a   Niino, Hitoshi ^b   Sagesaka, Yuko ^b   Masuyama, Keisuke ^c   Fukui, Hiroyuki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b 421 0516   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

allergy; epigallocatechin 3 O gallate; gene expression; histamine H1 receptors; histamine signaling; Th2 cytokines

Indexed keywords

EID: 77953277802     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.25.133     Document Type: Article

References (60)

1. Baba, K., Konno, A., and Takenaka, H. (Editors): Practical guideline for the management of allergic rhinitis in Japan. Life Science, Tokyo, pp. 3-5, 2005.
2. Marone, G., Granata, F., Spadaro, G., Genovese, A., and Triggiani, M.: The histamine-cytokine network in allergic inflammation. J. Allergy Clin. Immunol. 112, S83-S88, 2003.
3. Igaz, P., Novak, I., Lazar, E., Horvath, B., Heninger, E., and Faauls, A.: Bidirectional communication between histamine and cytokines. Inflamm. Res., 50, 123-128, 2001.
4. Abdelaziz, M., Devalia, J., Khair, O., Bayram, H., Prior, A., and Davies, R.: Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J. Allergy Clin. Immunol., 101, 410-420, 1998.
5. Fujikura, T., Shimosawa, T., Yakuo, I.: Regulatory effect of histamine H1 receptor antagonists on the expression or messenger RNA encoding CC chemokines in human nasal mucosa. J. Allergy Clin. Immunol., 107, 123-128, 2001.
6. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., Paul, W. E.: The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol., 17, 701-738, 1999.
7. Holgate, S. T.: The 1992 Cournand Lecture. Asthma: past, present and future. Eur. Respir. J., 6, 1507-1520, 1993.
8. Bischoff, S. C., Sellge, G., Lorentz, A., Sebald, W., Raab, R., Manns, M. P.: IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. USA, 96, 8080-8085, 1999.
9. Yamaguchi, M., Sayama, K., Yano, K., Lantz, C. S., Noben-Trauth, N., Ra, C., Costa, J. J., Galli, S. J.: IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J. Immunol., 162, 5455-5465, 1999.
10. Lagier, B., Lebel, B., Bousquest, J., Pene, J.: Different modulation by histamine of IL-4 and interferon-gamma (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol., 108, 545-551, 1997.
11. Krouwels, F. H., Hol, B. E., Lutter, R., Bruinier, B., Bast, A., Jansen, H. M., Out, T. A.: Histamine affects interleukin-4, interleukin-5, and interferon-γ production by human T cell clones from airways and blood. Am. J. Respir. Cell Mol. Biol., 18, 721-730, 1998.
12. Peters, J. M., Wegman, D. H.: Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease. Environ. Health Perspect, 11, 97-100, 1975.
13. Mapp, C. E., Boschetto, P., Zocca, E., Milani, G. F., Pivirotto, F., Tegazzin, V., Fabbri, L. M.: Pathogenesis of late asthmatic reactions induced by exposure to isocyanates. Bull. Eur. Physiopathol. Respir., 23, 583-586, 1987.
14. Abe, Y., Takeda, N., Irifune, M., Ogino, S., Kalubi, B., Imamura, I., Fukui, H., Wada, H., and Matsunaga T.: Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. Acta. Oto-Laryngol., 112, 703-709, 1992.
15. Kalubi, B., Takeda, N., Irifune, M., Ogino, S., Abe, Y., Hong, S. L., Yamano, M., Matsunaga, T. and Tohyama, M.: Nasal mucosa sensitization with toluene diisocyanate (TDI) increases preprotachykinin A (PPTA) and preproCGRP mRNA in guinea pig trigeminal ganglion neurons. Brain Res., 576, 287-296, 1992.
16. Takeda, N., Morita, M., Hasegawa, S., Horii, A., Kubo, T. and Matsunaga, T.: Neuropharmacology of motion sickness and emesis. A review. Acta Otolarygol, Suppl. 501, 10-15, 1993.
17. Abe, Y., Ogino, S., Irifune, M., Imamura, I., Liu, Y. Q., Fukui, H. and Matsunaga, T.: Histamine content, synthesis and degradation in nasal mucosa and lung of guinea-pigs treated with toluene diisocyanate (TDI). Clin. Exp. Allergy, 23, 512-517, 1993.
18. Kitamura, Y., Miyoshi, A., Murata, Y., Kalubi, B., Fukui, H. and Takeda, N.: Effect of glucocorticoid on up-regulation of H1R mRNA in nasal mucosa of rats sensitized by exposure to toluene diisocyanate. Acta. Oto-Laryngol., 124, 1053-1058, 2004.
19. Murata, Y., Miyoshi, A., Kitamura, Y., Takeda, N. and Fukui, H.: Up-regulation of H1Rs in an allergic rat nasal mucosa model. Inflamm. Res., 53, 11-12, 2004.
20. Tanaka, K., Okamoto, Y., Nagaya, Y., Nishimura, F., Takeoka, A., Hanada, S., Kohno, S. and Kawai, M.: A nasal allergy model developed in the guinea pig by intranasal application of 2, 4-toluene diisocyanate. Int. Arch. Allergy Appl. Immunol., 85, 392-397, 1998.
21. Irifune M.: Effect of sympathetic denervation in guinea pigs with nasal hypersensitivity. Jibirinnsho, 82, 719-727, 1989 (in Japanese).
22. Ban, M., Morel, G., Langonne, I., Huguet, N., Pepin, E. and Binet, S.: TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology, 218, 39-47, 2006.
23. Mapp, C., Boschetto, P., Miotto, D., De Rosa, E. and Fabbri, L. M.: Mechanisms of occupational asthma. Ann. Allergy Asthma Immunol., 83, 645-664, 1999.
24. Wisnewski, A. V. and Redlich, C. A.: Recent developments in diisocyanate asthma. Curr. Opin. Allergy Clin. Immunol., 1, 169-175, 2001.
25. Maestrelli, P., Saetta, M., Mapp, C. and Fabbri, L. M.: Diagnostic basis of occupational asthma. J. Investig. Allergol. Clin. Immunol., 7, 316-317, 1997.
26. Kitamura, Y., Das, A. K., Murata, Y., Maeyama, K., Dev, S., Wakayama, Y., Kalubi, B., Takeda, N. and Fukui, H.: Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats. Allergol. Int., 55, 279-286, 2006.
27. Dev, S., Mizuguchi, H., Das, A. K., Matsushita, C., Maeyama, K., Umehara, H., Ohtoshi, T., Kojima, J., Nishida, K., Takahashi, K. and Fukui, H.: Suppression of histamine signaling by probiotic Lac-B: a possible mechanism of its anti-allergic effect. J. Pharmacol. Sci., 107, 159-166, 2008.
28. Ruch, R. J., Cheng, S. J. and Klaunig, J. E.: Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis, 10, 1003-1008, 1989.
29. Yang, C. S., Yang, G. Y., Landau, J. M., Kim, S. and Liao, J.: Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp. Lung. Res., 24, 629-639, 1998.
30. Negishi, H., Xu, J. W., Ikeda, K., Njelekela, M., Nara, Y. and Yamori, Y.: Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J. Nutr., 134, 38-42, 2004.
31. Xu, R., Yokoyama, W. H., Irving, D., Rein, D., Walzem, R. L. and German, J. B.: Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis, 137, 29-36, 1998.
32. Shinozaki, T., Sugiyama, K., and Takeo, T.: Antiallergic effect of tea. J. Trad. Med., 11, 444-445, 1994 (in Japanease).
33. Abe, Y., Shinozaki, T., Sugiyama, K., and Takeo, T.: Antiallergic effect of tea II: Effect of tea on type IV allergic reaction. J. Trad. Med., 12, 452-453, 1995 (in Japanease).
34. Katiyar, S. K., Elmets, C. A., Agarwal, R. and Mukhtar, H.: Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem. Photobiol., 62, 855-861, 1995.
35. Shinozaki, T., Sugiyama, K., Nakazato, K., and Takeo, T.: Effect of tea extract, catechin and caffeine against type-I allergic reaction. Yakugaku Zasshi, 117, 448-454, 1994 (in Japanease).
36. Zhu, M., Gong, Y., Yang, Z., Ge, G., Han, C. and Chen, J.: Green tea and its major components ameliorate immune dysfunction in mice bearing Lewis lung carcinoma and treated with the carcinogen NNK. Nutr. Cancer, 35, 64-72, 1999.
37. Niino, H., Obara, K., Sagesaka, Y., Suzuki, M., Iigaya, N., Ogawa, K., Hayashi, M., and Cyong, J-C.: Clinical effect and safety of oolong tea “ogonkei” for seasonal allergic rhino-conjunctivitis caused by pollen. J. Trad. Med., 25, 10-17, 2008.
38. Ahn, H. Y., Xu, Y. and Davidge, S. T.: Epigallocatechin-3-O-gallate inhibits TNF-alpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci., 82, 964-968, 2008.
39. Matsuo, N., Yamada, K., Shoji, K., Mori, M. and Sugano, M.: Effect of tea polyphenols on histamine release from rat basophilic leukemia (RBL-2H3) cells: the structure-inhibitory activity relationship. Allergy, 52, 58-64, 1997.
40. Yamashita, K., Suzuki, Y., Matsui, T., Yoshimaru, T., Yamaki, M., Suzuki-Karasaki, M., Hayakawa, S. and Shimizu, K.: Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway. Biochem. Biophys. Res. Commun., 274, 603-608, 2000.
41. Maeda-Yamamoto, M., Inagaki, N., Kitaura, J., Chikumoto, T., Kawahara, H., Kawakami, Y., Sano, M., Miyase, T., Tachibana, H., Nagai, H. and Kawakami, T.: O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J. Immunol., 172, 4486-4492, 2004.
42. Tachibana, H., Koga, K., Fujimura, Y. and Yamada, K.: A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol., 11, 380-381, 2004.
43. Fujimura, Y., Umeda, D., Kiyohara, Y., Sunada, Y., Yamada, K. and Tachibana, H.: The involvement of the 67 kDa laminin receptor-mediated modulation of cytoskeleton in the degranulation inhibition induced by epigallocatechin-3-O-gallate. Biochem. Biophys. Res. Commun., 348, 524-531, 2006.
44. Fujimura, Y., Umeda, D., Yamada, K. and Tachibana, H.: The impact of the 67kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins. Arch. Biochem. Biophys., 476, 133-138, 2008.
45. Umeda, D., Tachibana, H. and Yamada, K.: Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67 kDa laminin receptor. Biochem. Biophys. Res. Commun., 333, 628-635, 2005.
46. Shirai, T., Sato, A. and Hara, Y.: Epigallocatechin gallate. The major causative agent of green tea-induced asthma. Chest., 106, 1801-1805, 1994.
47. Shirai, T., Reshad, K., Yoshitomi, A., Chida, K., Nakamura, H. and Taniguchi, M.: Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Clin. Exp. Allergy, 33, 1252-1525, 2003.
48. Tanaka, K., Okamoto, Y., Nagaya, Y., Nishimura, F., Takeoka, A., Hanada, S., Kohno, S. and Kawai, M.: A nasal allergy model developed in the guinea pig by intranasal application of 2, 4-toluene diisocyanate. Int. Arch. Allergy Appl. Immunol., 85, 392-397, 1988.
49. Goto, T., Yoshida, Y., Kiso, M., Nagashima, H.: Simultaneous analysis of individual catechins and caffeine in green tea. J. Chromatogr. A., 749, 295-299, 1996.
50. Das, A. K., Mizuguchi, H., Kodama, M., Dev, S., Umehara, H., Kitamura, Y., Matsushita, C., Takeda, N. and Fukui, H.: Sho-seiryu-to suppresses histamine signaling at transcriptional level in TDI-sensitized nasal allergy model rats. Allergol. Int. 2008 in press.
51. Das, A. K., Yoshimura, S., Mishima, R., Fujimoto, K., Mizuguchi, H., Dev, S., Wakayama, Y., Kitamura, Y., Horio, S., Takeda, N. and Fukui, H.: Stimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcription. J. Pharmacol. Sci., 103, 374-382, 2007.
52. Tepper, R. I., Levinson, D. A., Stanger, B. Z., Campos-Torres, J., Abbas, A. K., Leder, P.: IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell, 62, 457-467, 1990.
53. Li-Weber, M., Giasi, M. and Krammer, P. H.: Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem., 273, 32460-32466, 1998.
54. Li-Weber, M., Giaisi, M., Baumann, S., Pálfi, K. and Krammer, P. H.: NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur. J. Immunol., 34, 1111-1118, 2004.
55. Li-Weber, M. and Krammer, P. H.: Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol., 3, 534-543, 2003.
56. Ahmad, N., Gupita, S. and Mukhtar, H.: Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch. Biochem. Biophys., 376, 338-346, 2000.
57. Nomura, M., Ma, W., Chen, N., Bode, A. M. and Dong, Z.: Inhibition of 12-O-tetradecanoyl phorbol-13-acetate-induced NF-kappa B activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Carcinogenesis, 21, 1885-1890, 2000.
58. Syed, D. N., Afaq, F., Kweon, M. H., Hadi, N., Bhatia, N., Spiegelman, V. S. and Mukhtar, H.: Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene, 26, 673-682, 2007.
59. Dong, Z., Ma, W., Huang, C. and Yang, C. S.: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res., 57, 4414-4419, 1997.
60. Kim, S. H., Park, H. J., Lee, C. M., Choi, I. W., Moon, D. O., Roh, H. J., Lee, H. K. and Park, Y. M.: Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma. FEBS Lett., 580, 1883-1890, 2006.